Alector to Participate in Upcoming Healthcare Conferences
07 November 2022 - 11:00PM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology and innate immuno-oncology,
today announced that management will participate in the following
upcoming investor conferences:
- Guggenheim 4th Annual Immunology and Neurology Day (New York,
New York)
- Tuesday, November 15, 2022, at 3:20 p.m. ET, fireside chat
- Stifel 2022 Healthcare Conference (New York, New York)
- Wednesday, November 16, 2022, at 8:00 a.m. ET, fireside
chat
A webcast of each conference presentation will be available on
the “Events & Presentations” page within the Investors section
of the Alector website at http://investors.alector.com. Replays of
the webcasts will be available on the Alector website for 90 days
following the presentation dates.
About Alector
Alector is a clinical-stage biotechnology company pioneering
immuno-neurology, a novel therapeutic approach for the treatment of
neurodegenerative diseases, and innate immuno-oncology.
Immuno-neurology targets immune dysfunction as a root cause of
multiple pathologies that are drivers of degenerative brain
disorders. Alector has discovered and is developing a broad
portfolio of innate immune system programs, designed to
functionally repair genetic mutations that cause dysfunction of the
brain’s immune system and enable rejuvenated immune cells to
counteract emerging brain pathologies. Alector’s immuno-neurology
product candidates are supported by biomarkers and target
genetically defined patient populations in frontotemporal dementia
and Alzheimer’s disease. This scientific approach is also the basis
for the company’s immuno-oncology programs. Alector is
headquartered in South San Francisco, California. For additional
information, please visit www.alector.com.
Contacts:1AB (media) Dan Budwick
973-271-6085 dan@1abmedia.com
Argot Partners (investors) Laura Perry/Carrie McKim Argot
Partners 212.600.1902 alector@argotpartners.com
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Apr 2023 to Apr 2024